Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dalian Future International Trade Co., Ltd. (DFI) is a specialized supplier and distributor of active pharmaceutical ingredients (APIs), nutritional supplements, and chemical intermediates based in Dalian, China. Established in 2002, the company provides a wide range of products including vitamins, amino acids, and plant extracts to the global life sciences and healthcare industries. DFI operates as a critical link in the pharmaceutical supply chain, offering sourcing, quality assurance, and international logistics services. The company emphasizes compliance with international quality standards such as GMP, ISO, and HACCP to support the manufacturing of medicines and health supplements. Their business model is designed to bridge the gap between Chinese manufacturing capabilities and the requirements of international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dalian Future International.